Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824 Lin Gao, Paul Kwon, et al. Cancer Res 2004;64:689-695
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma Laurence Catley, Ellen Weisberg,et al. Blood 2003;102: 2615-2622
Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors Rebecca Kristeleit, Anthony Tolcher, et al. Clin Cancer Res 2008;14:6663-6673
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.